PMEL and glioma: In addition, gp100, MAGE-1, TRP-2 and EGFRvIII were detectable only in a part of gliomas restricting the number of potentially treatable patients (Chi et al, 1997; Liu et al, 2003, 2004b; Biernat et al, 2004).